Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

14 Aug 2018 16:00

RNS Number : 7967X
Synectics PLC
14 August 2018
 

 

14 August 2018

 

 

 

Synectics plc

(the "Company")

Director / PDMR shareholding

 

The Company announces that on 10 August 2018 the Trustee of the Company's HMRC Approved Employee Share Acquisition Plan ("ESAP") reinvested the Company's final dividend and allocated a total of 1,045 ordinary shares of 20 pence each in the Company to ESAP participants at a price of £2.07 per share.

As a result, the Company has been notified that Paul Webb and Mike Stilwell, directors of the Company, have acquired an interest in 85 shares and 53 shares respectively. Greg Alcorn, a PDMR of the Company, also acquired 6 shares. The resultant interests of the individuals are as follows:

Name

Position

Ordinary shares held

Interest in shares in Share Schemes

ResultantTotalInterest

% ofIssuedShare Capital

Paul Webb

Chief Executive

36,322

251,410

287,732

1.62%

Mike Stilwell

Finance Director

6,910

26,326

33,236

0.19%

Greg Alcorn

Divisional Director

0

10,434

10,434

0.06%

 

For further information, please contact:

Synectics plc

Tel: +44 (0) 1527 850 080

Jan Mitson, Deputy Company Secretary

legalandsecretarial@synecticsplc.com

www.synecticsplc.com

Stockdale Securities

Tel: +44 (0) 20 7601 6100

Tom Griffiths / Henry Willcocks

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHEALPLFSPPEFF

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS